{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:17:42Z","timestamp":1792898262945,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.chest.2024.03.027","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T07:04:40Z","timestamp":1710745480000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease"],"prefix":"10.1016","volume":"166","author":[{"given":"Ju Kwang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-5460","authenticated-orcid":false,"given":"Seonok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-3185","authenticated-orcid":false,"given":"Yong Pil","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5949-248X","authenticated-orcid":false,"given":"Kyung-Wook","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.chest.2024.03.027_bib1","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1093\/cid\/ciaa1381","article-title":"Mortality and prognostic factors of nontuberculous mycobacterial infection in Korea: a population-based comparative study","volume":"72","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.chest.2024.03.027_bib2","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1093\/cid\/ciaa810","article-title":"Trends in the nontuberculous mycobacterial disease mortality rate in Japan: a nationwide observational study, 1997-2016","volume":"73","author":"Harada","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.03.027_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"Koh","year":"2017","journal-title":"Eur Resp J"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4046\/trd.2018.0060","article-title":"Treatment of Mycobacterium avium complex pulmonary disease","volume":"82","author":"Kwon","year":"2019","journal-title":"Tuberc Respir Dis"},{"issue":"suppl 1","key":"10.1016\/j.chest.2024.03.027_bib5","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jfma.2020.05.006","article-title":"Treatment for Mycobacterium avium complex lung disease","volume":"119","author":"Pan","year":"2020","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2024.03.027_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2024.03.027_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202004-1418OC","article-title":"BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease","volume":"203","author":"Kim","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2024.03.027_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5588\/ijtld.15.0807","article-title":"Mortality among patients with pulmonary non-tuberculous mycobacteria disease","volume":"20","author":"Fleshner","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.03.027_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058664","article-title":"Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality","volume":"8","author":"Mitnick","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciu209","article-title":"Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death","volume":"59","author":"Vel\u00e1squez","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12879-021-06666-8","article-title":"Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.chest.2024.03.027_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(18)30235-2","article-title":"Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study","volume":"6","author":"Schnippel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2024.03.027_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.chest.2021.10.048","article-title":"Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality","volume":"161","author":"Im","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2024.03.027_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01522-21","article-title":"Efficacy of fluoroquinolones as substitutes for ethambutol or rifampin in the treatment of Mycobacterium avium complex pulmonary disease according to radiologic types","volume":"66","author":"Lee","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.chest.2024.03.027_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02261-21","article-title":"Treatment outcomes of cavitary nodular bronchiectatic-type Mycobacterium avium complex pulmonary disease","volume":"66","author":"Chae","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.chest.2024.03.027_bib17","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.athoracsur.2020.04.034","article-title":"Residual destructive lesions and surgical outcome in Mycobacterium avium complex pulmonary disease","volume":"110","author":"Togo","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.chest.2024.03.027_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, pulmonary cavitation, and matrix metalloproteinases","volume":"190","author":"Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2024.03.027_bib20","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis: the gateway of disease transmission","volume":"20","author":"Urbanowski","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.chest.2024.03.027_bib21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.chest.2016.06.005","article-title":"Lung function decline according to clinical course in nontuberculous mycobacterial lung disease","volume":"150","author":"Park","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2024.03.027_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"Meghji","year":"2020","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2024.03.027_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2024.03.027_bib24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"Kwak","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.chest.2024.03.027_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2017.04.175","article-title":"Safety and effectiveness of clofazimine for primary and refractory nontuberculous mycobacterial infection","volume":"152","author":"Martiniano","year":"2017","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2024.03.027_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.chest.2024.03.027_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2024.03.027_bib28","article-title":"Outcomes of inhaled amikacin and clofazimine-containing regimens for treatment of refractory Mycobacterium avium complex pulmonary disease","volume":"9","author":"Kim","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.chest.2024.03.027_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00528-22","article-title":"Clinical outcome with standard regimen plus clofazimine or moxifloxacin in cavitary Mycobacterium avium complex pulmonary disease","volume":"66","author":"Park","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.chest.2024.03.027_bib30","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41598-022-06022-z","article-title":"Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.chest.2024.03.027_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jgar.2020.01.004","article-title":"Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: a propensity score analysis","volume":"22","author":"Kwon","year":"2020","journal-title":"J\u00a0Glob Antimicrob Resist"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224003970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224003970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:22:03Z","timestamp":1731561723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224003970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0012369224003970"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.03.027","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}